Senate Bill Aims At Streamlining Combination Product Regulation
This article was originally published in The Tan Sheet
Executive Summary
A Senate bill would streamline device/drug combination registrations by letting FDA rely on prior PMAs and approved drug findings to help support new product approvals, among other reforms. It was introduced by Sen. Johnny Isakson, R-Ga., and co-sponsored by Sens. Robert Casey, D-Pa., and Pat Roberts, R-Kansas.
You may also be interested in...
Califf Supports Changing Combo Product Pathway; FDA Developing Proposal
FDA concepts for a new pathway could be ready for congressional scrutiny within a year, commissioner nominee Robert Califf says during his confirmation hearing.
Califf Supports Changing Combo Product Pathway; FDA Developing Proposal
FDA concepts for a new pathway could be ready for congressional scrutiny within a year, commissioner nominee Robert Califf says during his confirmation hearing.
21st Century Cures: Select Device Provisions
A run-down of key provisions impacting the medical device and diagnostics industry in the 21st Century Cures legislation, which passed the House by a 344-77 vote July 10.